← Back to Search

Other

Essential Oil Blend for Anxiety

N/A
Waitlist Available
Led By Jessie Hawkins, PhD
Research Sponsored by Franklin School of Integrative Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at 15 minutes

Summary

The purpose of this study is to assess the potential for a non-invasive sensory based intervention to reduce the stress associated with a COVID-19 diagnosis.

Eligible Conditions
  • Anxiety
  • Stress
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at 15 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at 15 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline in mood state on the Abbreviated Profile of Mood States (POMS)
Change from baseline in state anxiety on the State portion of the State Trait Anxiety Scale (STAI-S) at 15 minutes

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
Participants receive an active essential oil blend to inhale for 15 minutes. The blend contains plant based oils sourced from flowers and citrus plants.
Group II: ControlPlacebo Group1 Intervention
Participants receive an inert comparison to inhale for 15 minutes.

Find a Location

Who is running the clinical trial?

Franklin School of Integrative Health SciencesLead Sponsor
11 Previous Clinical Trials
2,643 Total Patients Enrolled
2 Trials studying Anxiety
28 Patients Enrolled for Anxiety
Franklin Health ResearchLead Sponsor
16 Previous Clinical Trials
3,409 Total Patients Enrolled
2 Trials studying Anxiety
28 Patients Enrolled for Anxiety
Jessie Hawkins, PhDPrincipal InvestigatorFranklin Health Research
3 Previous Clinical Trials
279 Total Patients Enrolled
~20 spots leftby Nov 2025